PET imaging of angiogenesis after myocardial infarction/reperfusion using a one-step labeled integrin-targeted tracer 18F-AlF-NOTA-PRGD2

被引：66
作者：
Gao, Haokao [1 ,2 ]
Lang, Lixin [1 ]
Guo, Ning [1 ]
Cao, Feng [2 ]
Quan, Qimeng [1 ]
Hu, Shuo [1 ]
Kiesewetter, Dale O. [1 ]
Niu, Gang [1 ]
Chen, Xiaoyuan [1 ]
机构：
[1] NIBIB, Lab Mol Imaging & Nanomed LOMIN, NIH, Bethesda, MD 20892 USA
[2] Fourth Mil Med Univ, Dept Cardiol, Xijing Hosp, Xian 710032, Peoples R China
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2012年 / 39卷 / 04期
基金：
美国国家卫生研究院; 美国国家科学基金会;
关键词：
PET imaging; Angiogenesis; Myocardial infarction; Integrin; RGD peptide; ALPHA(V)BETA(3) EXPRESSION; INFARCTION; PEPTIDES; THERAPY; F-18-FPPRGD2; ANTAGONISTS; AGENT; ACID; MICE;
D O I：
10.1007/s00259-011-2052-1
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
The alpha(v)beta(3) integrin represents a potential target for noninvasive imaging of angiogenesis. The purpose of this study was to evaluate a novel one-step labeled integrin alpha(v)beta(3)-targeting positron emission tomography (PET) probe, F-18-AlF-NOTA-PRGD2, for angiogenesis imaging in a myocardial infarction/reperfusion (MI/R) animal model. Male Sprague-Dawley rats underwent 45-min transient left coronary artery occlusion followed by reperfusion. The myocardial infarction was confirmed by ECG, F-18-fluorodeoxyglucose (FDG) imaging, and cardiac ultrasound. In vivo PET imaging was used to determine myocardial uptake of F-18-AlF-NOTA-PRGD2 at different time points following reperfusion. The control peptide RAD was labeled with a similar procedure and used to confirm the specificity. Ex vivo autoradiographic analysis and CD31/CD61 double immunofluorescence staining were performed to validate the PET results. Myocardial origin of the F-18-AlF-NOTA-PRGD2 accumulation was confirmed by F-18-FDG and autoradiography. PET imaging demonstrated increased focal accumulation of F-18-AlF-NOTA-PRGD2 in the infarcted area which started at day 3 (0.28 +/- 0.03%ID/g, p < 0.05) and peaked between 1 and 3 weeks (0.59 +/- 0.16 and 0.55 +/- 0.13%ID/g, respectively). The focal accumulation decreased but still kept at a higher level than the sham group after 4 months of reperfusion (0.31 +/- 0.01%ID/g, p < 0.05). Pretreatment with unlabeled arginine-glycine-aspartic acid (RGD) peptide significantly decreased tracer uptake, indicating integrin specificity of this tracer. At 1 week after MI/R, uptake of the control tracer F-18-AlF-NOTA-RAD that does not bind to integrin, in the infarcted area, was only 0.21 +/- 0.01%ID/g. Autoradiographic imaging showed the same trend of uptake in the myocardial infarction area. The time course of focal tracer uptake was consistent with the pattern of vascular density and integrin beta(3) expression as measured by CD31 and CD61 immunostaining analysis. PET imaging using one-step labeled F-18-AlF-NOTA-PRGD2 allows noninvasive visualization of ischemia/reperfusion-induced myocardial angiogenesis longitudinally. The favorable in vivo kinetics and easy production method of this integrin-targeted PET tracer facilitates its future clinical translation for lesion evaluation and therapy response monitoring in patients with occlusive cardiovascular diseases.
引用
收藏
页码：683 / 692
页数：10
相关论文
共 35 条
[11]   Rapid and Simple One-Step F-18 Labeling of Peptides [J].
Jacobson, Orit ;
Zhu, Lei ;
Ma, Ying ;
Weiss, Ido D. ;
Sun, Xilin ;
Niu, Gang ;
Kiesewetter, Dale O. ;
Chen, Xiaoyuan .
BIOCONJUGATE CHEMISTRY, 2011, 22 (03) :422-428
[12]   Molecular imaging of myocardial infarction [J].
Jaffer, Farouc A. ;
Sosnovik, David E. ;
Nahrendorf, Matthias ;
Weissleder, Ralph .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2006, 41 (06) :921-933
[13]   Preparation of a promising angiogenesis PET imaging agent:: 68Ga-labeled c(RGDyK)-isothiocyanatobenzyl-1,4,7-triazacyclononane-1,4,7-triacetic acid and feasibility studies in mice [J].
Jeong, Jae Min ;
Hong, Mee Kyung ;
Chang, Young Soo ;
Lee, Yun-Sang ;
Kim, Young Joo ;
Cheon, Gi Jeong ;
Lee, Dong Soo ;
Chung, June-Key ;
Lee, Myung Chul .
JOURNAL OF NUCLEAR MEDICINE, 2008, 49 (05) :830-836
[14]   Radiolabeled Arginine-Glycine-Aspartic Acid Peptides to Image Angiogenesis in Swine Model of Hibernating Myocardium [J].
Johnson, Lynne L. ;
Schofield, Lorraine ;
Donahay, Tammy ;
Bouchard, Mark ;
Poppas, Athena ;
Haubner, Roland .
JACC-CARDIOVASCULAR IMAGING, 2008, 1 (04) :500-510
[15]   Comparison Study of [18F]FAI-NOTA-PRGD2, [18F]FPPRGD2, and [68Ga]Ga-NOTA-PRGD2 for PET Imaging of U87MG Tumors in Mice [J].
Lang, Lixin ;
Li, Weihua ;
Guo, Ning ;
Ma, Ying ;
Zhu, Lei ;
Kiesewetter, Dale O. ;
Shen, Baozhong ;
Niu, Gang ;
Chen, Xiaoyuan .
BIOCONJUGATE CHEMISTRY, 2011, 22 (12) :2415-2422
[16]   68Ga-labeled multimeric RGD peptides for microPET imaging of integrin αvβ3 expression [J].
Li, Zi-Bo ;
Chen, Kai ;
Chen, Xiaoyuan .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 35 (06) :1100-1108
[17]   One-step radiosynthesis of 18F-AlF-NOTA-RGD2 for tumor angiogenesis PET imaging [J].
Liu, Shuanglong ;
Liu, Hongguang ;
Jiang, Han ;
Xu, Yingding ;
Zhang, Hong ;
Cheng, Zhen .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 (09) :1732-1741
[18]   18F-Labeled Galacto and PEGylated RGD Dimers for PET Imaging of αvβ3 Integrin Expression [J].
Liu, Shuanglong ;
Liu, Zhaofei ;
Chen, Kai ;
Yan, Yongjun ;
Watzlowik, Petra ;
Wester, Hans-Juergen ;
Chin, Frederick T. ;
Chen, Xiaoyuan .
MOLECULAR IMAGING AND BIOLOGY, 2010, 12 (05) :530-538
[19]   68Ga-labeled cyclic RGD dimers with Gly3 and PEG4 linkers: promising agents for tumor integrin αvβ3 PET imaging [J].
Liu, Zhaofei ;
Niu, Gang ;
Shi, Jiyun ;
Liu, Shuanglong ;
Wang, Fan ;
Liu, Shuang ;
Chen, Xiaoyuan .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 (06) :947-957
[20]   In vivo molecular imaging of angiogenesis, targeting αvβ3 integrin expression, in a patient after acute myocardial infarction [J].
Makowski, Marcus R. ;
Ebersberger, Ullrich ;
Nekolla, Stephan ;
Schwaiger, Markus .
EUROPEAN HEART JOURNAL, 2008, 29 (18) :2201-2201
1234